English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#oncology search results

ChandrakanthMv's profile picture. Medical Oncologist (Breast • GU • GI) Simplifying Oncology for DoctorsI Building MV Onco I Head Academics | Narayana Health Kolkata
MV Chandrakanth
@ChandrakanthMv
Apr 23

HCC is one of the few cancers you can diagnose WITHOUT biopsy 👇 Right patient + arterial enhancement + washout = diagnosis LI-RADS LR-5 seals it Simple. Practical. Powerful. #MVOnco #HCC #Oncology #MedEd

ChandrakanthMv's tweet image. HCC is one of the few cancers you can diagnose WITHOUT biopsy 👇 Right patient + arterial enhancement + washout = diagnosis LI-RADS LR-5 seals it Simple. Practical. Powerful. #MVOnco #HCC #Oncology #MedEd
2
11
31
17
984
NEJM's profile picture. The New England Journal of Medicine is the world’s leading medical journal and website.
NEJM
@NEJM
Apr 25

Original Article: Transdermal Estradiol Patches in Locally Advanced Prostate Cancer (STAMPEDE-1 and PATCH trials) nejm.org/doi/full/10.10… #Oncology

NEJM's tweet image. Original Article: Transdermal Estradiol Patches in Locally Advanced Prostate Cancer (STAMPEDE-1 and PATCH trials) nejm.org/doi/full/10.10… #Oncology
0
5
23
4
7K
AATSHQ's profile picture. The American Association for Thoracic Surgery is the premier association for cardiothoracic surgeons in the world.
AATS
 @AATSHQ
Apr 24

SPONSORED: Join us Sunday, 5/3, at 6:15 PM CDT, for our resectable #NSCLC live, in-person symposium Drs. Stiles (@BrendonStilesMD), Spicer (@doctorjspicer), and Woodard (@GavittWoodard) during #AATS2026 bit.ly/Chicago26-T #Oncology

AATSHQ's tweet image. SPONSORED: Join us Sunday, 5/3, at 6:15 PM CDT, for our resectable #NSCLC live, in-person symposium Drs. Stiles (@BrendonStilesMD), Spicer (@doctorjspicer), and Woodard (@GavittWoodard) during #AATS2026 bit.ly/Chicago26-T #Oncology
0
2
10
1
592
JAMA_current's profile picture. JAMA is an international peer-reviewed general medical journal published weekly online and in print, and a member of the @JAMANetwork family of journals.
JAMA
@JAMA_current
Apr 23

💬 Editorial: The #Oncology Care Model achieved episode savings largely through supportive care medication changes, but net losses and limited impact on hospital use shaped the successor model. ja.ma/4mKtIrT

JAMA_current's tweet image. 💬 Editorial: The #Oncology Care Model achieved episode savings largely through supportive care medication changes, but net losses and limited impact on hospital use shaped the successor model. ja.ma/4mKtIrT
0
1
4
0
2K
OncLive's profile picture. Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
OncLive.com
@OncLive
Apr 25

💥 @US_FDA has issued a CRL for RP1 plus nivolumab in advanced melanomaelated to the findings from the single-arm phase 1/2 IGNYTE trial. Read more here ➡️: hubs.ly/Q04drQc10 #melsm #oncology

0
2
4
0
388
JAMA_current's profile picture. JAMA is an international peer-reviewed general medical journal published weekly online and in print, and a member of the @JAMANetwork family of journals.
JAMA
@JAMA_current
Apr 23

The Medicare #Oncology Care Model (OCM) was associated with modest reductions in Medicare payments for beneficiaries receiving #chemotherapy for cancer; however, overall program costs exceeded these spending reductions. ja.ma/4tVera2

JAMA_current's tweet image. The Medicare #Oncology Care Model (OCM) was associated with modest reductions in Medicare payments for beneficiaries receiving #chemotherapy for cancer; however, overall program costs exceeded these spending reductions. ja.ma/4tVera2
0
1
2
1
2K
OncLive's profile picture. Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
OncLive.com
@OncLive
Apr 23

Australia’s TGA has approved tafasitamab in combination with rituximab and lenalidomide for the treatment of adult patients with relapsed or refractory follicular lymphoma #lymsm #oncology Read more on the latest global health authority to green light this combination:

0
2
3
0
317
OncLive's profile picture. Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
OncLive.com
@OncLive
Apr 25

⚛️ “We are very delighted to present this regimen now as an option for treatment of patients with platinum-resistant ovarian cancer,” said Alexander B. Olawaiye, MD, of @UPMC on relacorilant plus nab-paclitaxel in PROC. Read more here 📈: hubs.li/Q04dr-LS0 #ovca #oncology

0
2
3
0
388
OncLive's profile picture. Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
OncLive.com
@OncLive
9 m

WATCH 👀: Dallas Gallagher, DNP, FNP-C, AOCNP, of @UofCAHealth discusses the importance of a patient-focused approach when managing the emotional weight of a pancreatic cancer diagnosis. See the whole video here ➡️: hubs.li/Q04dtP7d0 #pancsm #oncology

0
0
0
0
33
CancerNetwrk's profile picture. Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.
CancerNetwork®
@CancerNetwrk
Apr 14

Topline findings from the phase 3 RASolute 302 trial showed that daraxonrasib monotherapy yielded an OS HR of 0.4 vs standard chemo in metastatic PDAC. ⬇️ Read more ⬇️ hubs.li/Q04bS4hp0 #pancsm #PancreaticCancer #Oncology #Cancer

CancerNetwrk's tweet image. Topline findings from the phase 3 RASolute 302 trial showed that daraxonrasib monotherapy yielded an OS HR of 0.4 vs standard chemo in metastatic PDAC. ⬇️ Read more ⬇️ hubs.li/Q04bS4hp0 #pancsm #PancreaticCancer #Oncology #Cancer
0
2
3
0
478
OncLive's profile picture. Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
OncLive.com
@OncLive
Apr 17

WATCH: @fangdisun highlights the importance of PD-L1 testing for head and neck cancer. @StanfordMed @StanfordCancer #hncsm #oncology Check out our site for more head and neck cancer insights! onclive.com/clinical/head-…

0
1
6
0
578
ASCOPost's profile picture. News and views from the world of clinical oncology and hematology
The ASCO Post
 @ASCOPost
Apr 7

🖥️ #ASCOAI: @drsarahsam of @dfci_breastonc reflects on how #AI is and will continue to transform #oncology practice, potentially impacting the practice of second opinions. Read her perspective here: ascoai.org/articles/2026/…

ASCOPost's tweet image. 🖥️ #ASCOAI: @drsarahsam of @dfci_breastonc reflects on how #AI is and will continue to transform #oncology practice, potentially impacting the practice of second opinions. Read her perspective here: ascoai.org/articles/2026/…
2
5
5
3
773
KidneyCancer's profile picture. The KCA is a global community dedicated to serving and empowering patients and caregivers, and leading change through advocacy, research, and education.
Kidney Cancer
 @KidneyCancer
Apr 17

Shake the hand of someone who… 🤝 Part ONE! Connecting across disciplines, experiences, and a shared mission to move kidney cancer research forward. #IKCSEU26 #KidneyCancer #Oncology #CancerResearch

1
10
20
1
1K
CancerNetwrk's profile picture. Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.
CancerNetwork®
@CancerNetwrk
Apr 14

"For over a decade, the transformative potential of CAR-T therapy has been constrained by a fundamental bottleneck: manufacturing." Check out @YLeyfman latest submission to CancerNetwork here: hubs.li/Q04bSbJZ0 #mmsm #Myeloma #Oncology #Cancer

1
4
8
0
2K
OncLive's profile picture. Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
OncLive.com
@OncLive
Apr 15

Did you know 20% of BRAF-mutated mCRC patients also have MSI-H? Tanios S. Bekaii-Saab, MD breaks down more biomarker insights at the OncLive Biomarker Consortium. Explore More: hubs.li/Q04bQ1nM0 #CRCSM #Oncology #Biomarkers @GIcancerDoc

1
2
7
0
658
ASCOPost's profile picture. News and views from the world of clinical oncology and hematology
The ASCO Post
 @ASCOPost
Apr 11

🖥️ #ASCOAI: Catch up on this week’s #oncology + #AI updates: 🔹 Lab-on-a-chip drug sensitivity in pediatric leukemia 🔹 VALID framework for AI data reliability 🔹 AI uncovering misdiagnosed lung metastases 🎥 Watch the full brief: ascoai.org/videos/weekly-…

ASCOPost's tweet image. 🖥️ #ASCOAI: Catch up on this week’s #oncology + #AI updates: 🔹 Lab-on-a-chip drug sensitivity in pediatric leukemia 🔹 VALID framework for AI data reliability 🔹 AI uncovering misdiagnosed lung metastases 🎥 Watch the full brief: ascoai.org/videos/weekly-…
0
3
3
0
619
OncLive's profile picture. Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
OncLive.com
@OncLive
9 m

WATCH 👀: Dallas Gallagher, DNP, FNP-C, AOCNP, of @UofCAHealth discusses the importance of a patient-focused approach when managing the emotional weight of a pancreatic cancer diagnosis. See the whole video here ➡️: hubs.li/Q04dtP7d0 #pancsm #oncology

0
0
0
0
33
MD_Goksel's profile picture. Antalya City Hospital / Medical Oncology
Halil Göksel Güzel MD
 @MD_Goksel
20 m

🏌Old Player, New Field. RegoMel Phase II trial! 🔬 Regorafenib shows promising efficacy & manageable safety in patients with advanced, pretreated melanoma, especially in KIT-mutant cases. ​🔗 doi.org/10.1016/j.esmo… #Melanoma #Oncology #MedTwitter

0
0
0
0
10
oncodaily's profile picture. Your daily dose of hope, inspiration, and information in the fight against cancer. OncoDaily - The Voice of Oncology
OncoDaily
@oncodaily
39 m

Two Weeks Advancing Cancer Care Education in Zimbabwe - Enrique Soto Perez de Celis @EnriqueSoto8 oncodaily.com/voices/enrique… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

oncodaily's tweet image. Two Weeks Advancing Cancer Care Education in Zimbabwe - Enrique Soto Perez de Celis @EnriqueSoto8 oncodaily.com/voices/enrique… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter
0
0
0
0
26
oncodaily's profile picture. Your daily dose of hope, inspiration, and information in the fight against cancer. OncoDaily - The Voice of Oncology
OncoDaily
@oncodaily
54 m

ASCO - Thank You To Our Volunteers For Successful ASCO Advocacy Summit @ASCO oncodaily.com/voices/asco-49… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitte

oncodaily's tweet image. ASCO - Thank You To Our Volunteers For Successful ASCO Advocacy Summit @ASCO oncodaily.com/voices/asco-49… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitte
0
0
0
0
34
oncodaily's profile picture. Your daily dose of hope, inspiration, and information in the fight against cancer. OncoDaily - The Voice of Oncology
OncoDaily
@oncodaily
1 h

Serving as Interpreter in a China–US Lung Cancer Exchange at AACR 2026 - Wenxue Ma (@xue_lab) @AACR oncodaily.com/voices/491314 #OncoDaily #Oncology #Cancer #Health #Medicine #MedX

oncodaily's tweet image. Serving as Interpreter in a China–US Lung Cancer Exchange at AACR 2026 - Wenxue Ma (@xue_lab) @AACR oncodaily.com/voices/491314 #OncoDaily #Oncology #Cancer #Health #Medicine #MedX
0
0
0
0
41
dd4char's profile picture.
Science Updates
 @dd4char
1 h

Oncology clinical trials market hits $15.98B, heading to $20.4B by 2030 AI, personalized medicine & gene therapy are accelerating new cancer treatments. More trials = more hope. Science won’t stop 💪 #CancerResearch #Oncology #ClinicalTrials #Biotech #MedicalScience

dd4char's tweet image. Oncology clinical trials market hits $15.98B, heading to $20.4B by 2030 AI, personalized medicine & gene therapy are accelerating new cancer treatments. More trials = more hope. Science won’t stop 💪 #CancerResearch #Oncology #ClinicalTrials #Biotech #MedicalScience
0
1
3
0
11
MAvilaMD's profile picture. Gynecologic Oncologist @Moffittnews. Assistant PD @MoffittGYNONC. Targeted Therapy Explorer. Trained @MDAndersonnews. Views mine.
Dr.Monica Avila
 @MAvilaMD
2 h

Our new #oncology review on #uterinesarcomas comes with a #rapidfire 🔥 table linking Sarcoma type 🧫 to Genomics 🧬. Nice collab bw @MoffittGYNONC & Moffitt sarcoma @Sciencedirect! @MoffittNews url.us.m.mimecastprotect.com/s/U0-2C31YB8Ip…

MAvilaMD's tweet image. Our new #oncology review on #uterinesarcomas comes with a #rapidfire 🔥 table linking Sarcoma type 🧫 to Genomics 🧬. Nice collab bw @MoffittGYNONC & Moffitt sarcoma @Sciencedirect! @MoffittNews url.us.m.mimecastprotect.com/s/U0-2C31YB8Ip…
0
2
5
0
140
OncLive's profile picture. Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
OncLive.com
@OncLive
2 h

🔬 High resolution rates and low number of discontinuations due to hematologic PSEOIs were shown for first-line niraparib maintenance in epithelial ovarian cancer according to a real-world analysis. Read more here 📈: hubs.li/Q04dtP0P0 #ovca #oncology

0
1
3
0
195
stocks338888's profile picture.
stocks
 @stocks338888
2 h

$SNTI #CellTherapy #Oncology #AML #stocks If closes above 1 by Thursday next week, then RS issue is averted for few more months . Note stock market reaction is based on lack of cash but gene circuits alone can drive senti valuation even if 202 data fails to impress.

0
0
2
0
19
stocks338888's profile picture.
stocks
 @stocks338888
2 h

$SNTI #CellTherapy #Oncology #AML #stocks 202 durability data update and fda alignment 🔑. Durability holds or betters and alignment with fda, then 💰. This may come mid -late 2026. If Durability fails or alignment with fda not established, then issues but again holding co

1
0
1
0
13
stocks338888's profile picture.
stocks
 @stocks338888
2 h

$SNTI #CellTherapy #Oncology #AML #stocks Now lets visit worst scenario: if 202 fails - nothing , as a holding company, main asset will be gene circuits . Senti - spark gene circuit pact in 2021 was around 600 mil. So heres my thoughts on what may come next and how I prepare

1
0
0
0
14
OGdukeneurosurg's profile picture. Neurosurgeon/ Professor at Duke University & TV Producer, Writer, Actor, and Consultant.
Oren Gottfried, MD
@OGdukeneurosurg
2 h

She’s had 12 different cancers and she’s still alive. The first tumor appeared at age 2… and then they just kept coming. If this was your reality, would you live your life angry or just be grateful to be alive? #Cancer #Oncology #MedicalMystery #Survival #Health

4
2
15
1
2K
oncodaily's profile picture. Your daily dose of hope, inspiration, and information in the fight against cancer. OncoDaily - The Voice of Oncology
OncoDaily
@oncodaily
2 h

Honored and Grateful for Recognition at ISCO 2026 - Wael El-Sheshtawy (@Waelhshesh) oncodaily.com/voices/wael-el… #OncoDaily #Oncology #Cancer #Health #Medicine #ISCO2026 #MedX

oncodaily's tweet image. Honored and Grateful for Recognition at ISCO 2026 - Wael El-Sheshtawy (@Waelhshesh) oncodaily.com/voices/wael-el… #OncoDaily #Oncology #Cancer #Health #Medicine #ISCO2026 #MedX
0
0
0
0
63
montypal's profile picture. @cityofhope & @cityofhopeoc prof w focus on #kidneycancer. Want to contribute to my work? E-mail mmayne@coh.org.
Sumanta K. Pal, MD, FASCO
@montypal
2 h

Thoroughyly enjoyed sitting down with @DrArturoAI for this @ASCO Daily News podcast. He's clearly thought through some of the most intricate issues surrounding the application of AI in #oncology practice - listen in for a perspective on how he feels AI will be (and already is!)

ASCO's profile picture. Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
ASCO
 @ASCO
Apr 16

🎙 @montypal of @cityofhope and @DrArturoAI of @mystlukes discuss the risks of implementing #AI in clinical practice & approaches to help oncologists maintain their decision-making agility on the latest episode of the #ASCODailyNews Podcast: bit.ly/4dQrp43

ASCO's tweet image. 🎙 @montypal of @cityofhope and @DrArturoAI of @mystlukes discuss the risks of implementing #AI in clinical practice & approaches to help oncologists maintain their decision-making agility on the latest episode of the #ASCODailyNews Podcast: bit.ly/4dQrp43
0
9
15
0
2K
1
4
6
1
507
oncodaily's profile picture. Your daily dose of hope, inspiration, and information in the fight against cancer. OncoDaily - The Voice of Oncology
OncoDaily
@oncodaily
4 h

Myeloma Paper of the Day, April 26th, Suggested by Robert Orlowski @Myeloma_Doc oncodaily.com/voices/myeloma… #OncoDaily #Oncology #Cancer #Health #Medicine #MM #Myeloma

oncodaily's tweet image. Myeloma Paper of the Day, April 26th, Suggested by Robert Orlowski @Myeloma_Doc oncodaily.com/voices/myeloma… #OncoDaily #Oncology #Cancer #Health #Medicine #MM #Myeloma
0
0
0
0
58
oncodaily's profile picture. Your daily dose of hope, inspiration, and information in the fight against cancer. OncoDaily - The Voice of Oncology
OncoDaily
@oncodaily
4 h

Childhood Cancer International (@IntChildCancer) - Africa Regional Conference 2026 Uniting Voices for Childhood Cancer Progress oncodaily.com/voices/cci-491… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

oncodaily's tweet image. Childhood Cancer International (@IntChildCancer) - Africa Regional Conference 2026 Uniting Voices for Childhood Cancer Progress oncodaily.com/voices/cci-491… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter
0
0
0
0
61
oncodaily's profile picture. Your daily dose of hope, inspiration, and information in the fight against cancer. OncoDaily - The Voice of Oncology
OncoDaily
@oncodaily
4 h

King Hussein Cancer Foundation and Center - Insurance Care for Timely Breast Cancer Treatment (@khcfusa) oncodaily.com/voices/king-hu… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

oncodaily's tweet image. King Hussein Cancer Foundation and Center - Insurance Care for Timely Breast Cancer Treatment (@khcfusa) oncodaily.com/voices/king-hu… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter
0
0
0
0
54
myESMO's profile picture. The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.

ESMO - Eur. Oncology

@myESMO
TheLancetOncol's profile picture. The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=35·9.

The Lancet Oncology

@TheLancetOncol
AmgenOncology's profile picture. Advancing All Angles of Care. Tweets intended for U.S. audience. See our Community Guidelines: https://t.co/WUbqtYaEAr.

Amgen Oncology

@AmgenOncology
JCO_ASCO's profile picture. @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.

Journal of Clinical Oncology

@JCO_ASCO
OncologyTimes's profile picture. Reporting essential clinical news w/ independent analysis for cancer care professionals to optimize patient care & outcomes; oncology/hematology

Oncology Times

@OncologyTimes
Annals_Oncology's profile picture. Medical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.

Annals of Oncology

@Annals_Oncology
JAMAOnc's profile picture. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

JAMA Oncology

@JAMAOnc
FDAOncology's profile picture. FDA Oncology Center of Excellence expedites medical product development to improve the lives of people with cancer.

FDA Oncology

@FDAOncology
MedscapeOnc's profile picture. Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.

Medscape Oncology

@MedscapeOnc
PfizerOncMed's profile picture. Pfizer sponsored. Posts are intended for US healthcare professionals (HCPs) only and may not be suitable outside the US. https://t.co/jHvCqeBej4

Pfizer Oncology Medical

@PfizerOncMed
VJOncology's profile picture. The Video Journal of Oncology is dedicated to providing up-to-date information & international expertise on #Oncology #BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm

VJ Oncology

@VJOncology
oncologynursing's profile picture. Professional association of more than 35,000 members committed to promoting excellence in oncology nursing and the transformation of cancer care.

Oncology Nursing Society

@oncologynursing
Blagosklonny's profile picture. Rapamycin for immortality. Hyperfunction theory of aging. Near-curing of incurable cancer Editor-in-Chief: https://t.co/vOLFBqirGU & https://t.co/ivXaGJvXZo

Mikhail V. Blagosklonny, MD PhD Professor Oncology

@Blagosklonny
TargetedOnc's profile picture. Oncology news and insights from leading researchers and cancer centers.

Targeted Oncology

@TargetedOnc
OncBrothers's profile picture. Practice changing discussions by community oncologists-Rohit Gosain @RoswellPark & Rahul Gosain @WilmotCancer. OwnViews/NoMedAdvice.COI https://t.co/cJOjp0RvQE

Oncology Brothers

@OncBrothers
TakedaOncology's profile picture. Official Twitter handle of Takeda’s Oncology Business. We aspire to cure cancer, with inspiration from patients & innovation from everywhere. Guidelines below:

Takeda Oncology

@TakedaOncology
SocSurgOnc's profile picture. The mission of the Society of Surgical Oncology is to improve patient care by advancing the science and practice of surgical oncology worldwide. #SSO

Society of Surgical Oncology

@SocSurgOnc
oncologytube's profile picture. Stay Up To Date with our Newsletter: https://t.co/BQxZ2gkon8 Delivering top-quality multimedia to oncologists, hematologists, and cancer pros!

Oncology Tube

@oncologytube
AnnSurgOncol's profile picture. The Leading Resource in Surgical Oncology "Every 10 seconds an article from Annals of Surgical Oncology is downloaded"

Annals of Surgical Oncology

@AnnSurgOncol
JCOOP_ASCO's profile picture. Impactful information & insights to changes & challenges inherent in delivering equitable, high-quality oncology care. Part of @JCO_ASCO family of journals.

JCO Oncology Practice

@JCOOP_ASCO
JCOGO_ASCO's profile picture. Cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources. Part of @JCO_ASCO family of journals.

JCO Global Oncology

@JCOGO_ASCO
EurUrolOncol's profile picture. @EUPlatinum Journal Family • EiC Prof. @MRoupret • Official journal of @uroweb #ESOU section • IF 9.3

European Urology Oncology

@EurUrolOncol
VHIO's profile picture. Leading translational research to accelerate & advance personalized and targeted therapies against cancer. @iCERCA centre

Vall d’Hebron Institute of Oncology (VHIO)

@VHIO
ESSOnews's profile picture. Advancing the science and practice of #cancersurgery for the benefit of #cancerpatients #CureCancerTogether @EJSOtweets @myBRESO

European Society of Surgical Oncology (ESSO)

@ESSOnews
Applied_RadOnc's profile picture. ARO publishes peer-reviewed clinical review articles, research, and clinical cases for Radiation Oncology professionals online.

Applied Radiation Oncology

@Applied_RadOnc
OncNursingNews's profile picture. Educating Nurses & Providers

Oncology Nursing News

@OncNursingNews
JNeurooncol's profile picture. The official twitter account for the Journal of Neuro-Oncology (JNO), the official journal of the AANS/CNS Section on Tumors

Journal of Neuro-Oncology

@JNeurooncol
ejsotweets's profile picture. Dedicated to publishing cutting edge cancer surgery research, the European Journal of Surgical Oncology (EJSO) is the publication of @ESSOnews and @BASO_ACS

European Journal of Surgical Oncology

@ejsotweets
NRGonc's profile picture. Advancing cancer research, improving lives.

NRG Oncology

@NRGonc
MDedgeHemOnc's profile picture. MDedge Hematology & Oncology provides the most important and up to date information and news for oncologists. Now part of the Medscape Professional Network.

MDedge Hematology & Oncology

@MDedgeHemOnc
TheUSONetwork's profile picture. The US Oncology Network is one of the nation’s largest networks of community-based oncology physicians dedicated to advancing cancer care in America.

The US Oncology Network

@TheUSONetwork
SocietyofHemOnc's profile picture. The only worldwide society dedicated to hematologic malignancies. Join SOHO FREE➡️ https://t.co/6ft3NJoQLu Register for SOHO 2026: https://t.co/9s58Gec5KO

Society of Hematologic Oncology (SOHO)

@SocietyofHemOnc
ALLIANCE_org's profile picture. Utilizing the best science to develop promising new cancer therapies and prevention strategies for cancer.

Alliance for Clinical Trials in Oncology

@ALLIANCE_org
UroOnc's profile picture. Created in 1985, the SUO enables qualified members in improving the care of patients with malignant GU diseases. This account does not provide medical advice.

Society of Urologic Oncology

@UroOnc
DFCI_BreastOnc's profile picture. Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425

Dana-Farber’s Breast Oncology Center

@DFCI_BreastOnc
BreastOncology's profile picture. Tweeting, sharing, liking, plugging, promoting and quoting the latest breakthroughs in breast cancer treatment. #bcsm

Breast Oncology

@BreastOncology
HOGONC's profile picture. is committed to providing the highest quality healthcare, and to enhancing the quality of life of our patients and their loved ones.

Highlands Oncology Group

@HOGONC
FrontOncology's profile picture. Research and updates from all @FrontiersIn journals in the field of oncology. #openaccess

Frontiers - Oncology

@FrontOncology
LillyOncMed's profile picture. Dedicated to communicating the latest science & disease state education from Lilly Oncology. Intended for U.S. HCPs. Community Guidelines: https://t.co/1q8vAe63mK

Lilly Oncology Medical

@LillyOncMed
OncEd's profile picture. Evidence-based, educational resources for the oncology community. Authored exclusively by a leading international faculty of oncology.

OncologyEducation

@OncEd
VJHemOnc's profile picture. The Video Journal of Hematology & Hematological Oncology is dedicated to providing up-to-date information & international expertise
VJHemOnc
@VJHemOnc
Apr 25

AZD5492. CLL/NHL. A new wave of T-cell engagers 🧬 @mshadman is live at #iwCART26! Stay tuned for the highlights! #CellTherapy #Oncology #Immunotherapy

VJHemOnc's tweet image. AZD5492. CLL/NHL. A new wave of T-cell engagers 🧬 @mshadman is live at #iwCART26! Stay tuned for the highlights! #CellTherapy #Oncology #Immunotherapy
0
3
6
2
381
VJHemOnc's profile picture. The Video Journal of Hematology & Hematological Oncology is dedicated to providing up-to-date information & international expertise
VJHemOnc
@VJHemOnc
Apr 25

Richter's transformation. CAR-T vs. bispecifics vs. small molecules. 🧬 Alexey Danilov (@DanilovLab) is on at #iwCART26 - which approach will come out on top? #CLL #Oncology #CellTherapy

VJHemOnc's tweet image. Richter's transformation. CAR-T vs. bispecifics vs. small molecules. 🧬 Alexey Danilov (@DanilovLab) is on at #iwCART26 - which approach will come out on top? #CLL #Oncology #CellTherapy
0
4
9
3
560
NEJMClinician's profile picture. NEJM Clinician is a new digital resource delivering contextualized insights of the most impactful and practice-changing research in medicine.
NEJM Clinician
 @NEJMClinician
Apr 25

Pegfilgrastim is recommended in patients at high risk for developing chemotherapy-associated febrile neutropenia, but it can cause severe, persistent bone pain. Could adjusting the timing reduce pain? #Oncology

NEJMClinician's tweet image. Pegfilgrastim is recommended in patients at high risk for developing chemotherapy-associated febrile neutropenia, but it can cause severe, persistent bone pain. Could adjusting the timing reduce pain? #Oncology
2
0
5
0
811
ASCOPost's profile picture. News and views from the world of clinical oncology and hematology
The ASCO Post
 @ASCOPost
Apr 25

🖥️ #ASCOAI: New week, new #AI insights in #oncology. Top updates: 🔹 #AACR26 AI innovations 🔹 Precision diagnostics + risk modeling 🔹 New AI chatbot entering clinical workflows 🎥 Watch the weekly brief: ascoai.org/videos/weekly-…

ASCOPost's tweet image. 🖥️ #ASCOAI: New week, new #AI insights in #oncology. Top updates: 🔹 #AACR26 AI innovations 🔹 Precision diagnostics + risk modeling 🔹 New AI chatbot entering clinical workflows 🎥 Watch the weekly brief: ascoai.org/videos/weekly-…
0
3
2
0
465
ChandrakanthMv's profile picture. Medical Oncologist (Breast • GU • GI) Simplifying Oncology for DoctorsI Building MV Onco I Head Academics | Narayana Health Kolkata
MV Chandrakanth
@ChandrakanthMv
Apr 5

HER2 Heterogeneity — the hidden reason T-DXd fails 👇 Not all HER2+ tumors are uniform. 👉 HER2-high cells → killed 👉 HER2-low cells → escape → regrow This isn’t resistance. It’s selection. 💡 “T-DXd kills the bulk — but misses the seeds.” #Oncology #BreastCancer #MedEd

ChandrakanthMv's tweet image. HER2 Heterogeneity — the hidden reason T-DXd fails 👇 Not all HER2+ tumors are uniform. 👉 HER2-high cells → killed 👉 HER2-low cells → escape → regrow This isn’t resistance. It’s selection. 💡 “T-DXd kills the bulk — but misses the seeds.” #Oncology #BreastCancer #MedEd
3
7
25
13
2K
ChandrakanthMv's profile picture. Medical Oncologist (Breast • GU • GI) Simplifying Oncology for DoctorsI Building MV Onco I Head Academics | Narayana Health Kolkata
MV Chandrakanth
@ChandrakanthMv
Mar 31

Today I learnt 👇 Why 5-FU is less effective in dMMR CRC Same drug. Same DNA damage. But without MMR, damage isn’t recognized → less apoptosis. Not true resistance—failure of damage sensing. #MVOnco #CRC #Oncology

ChandrakanthMv's tweet image. Today I learnt 👇 Why 5-FU is less effective in dMMR CRC Same drug. Same DNA damage. But without MMR, damage isn’t recognized → less apoptosis. Not true resistance—failure of damage sensing. #MVOnco #CRC #Oncology
1
31
83
46
3K
ChandrakanthMv's profile picture. Medical Oncologist (Breast • GU • GI) Simplifying Oncology for DoctorsI Building MV Onco I Head Academics | Narayana Health Kolkata
MV Chandrakanth
@ChandrakanthMv
Apr 23

HCC is one of the few cancers you can diagnose WITHOUT biopsy 👇 Right patient + arterial enhancement + washout = diagnosis LI-RADS LR-5 seals it Simple. Practical. Powerful. #MVOnco #HCC #Oncology #MedEd

ChandrakanthMv's tweet image. HCC is one of the few cancers you can diagnose WITHOUT biopsy 👇 Right patient + arterial enhancement + washout = diagnosis LI-RADS LR-5 seals it Simple. Practical. Powerful. #MVOnco #HCC #Oncology #MedEd
2
11
31
17
984
ASCOPost's profile picture. News and views from the world of clinical oncology and hematology
The ASCO Post
 @ASCOPost
Apr 2

🖥️#ASCOAI: From biomarker discovery to ambient documentation, #AI is reshaping #oncology care delivery. In this webinar, experts discuss how they are integrating these tools across the full patient journey in real-world use cases. 🎥 Watch the webinar: ascoai.org/videos/webinar…

ASCOPost's tweet image. 🖥️#ASCOAI: From biomarker discovery to ambient documentation, #AI is reshaping #oncology care delivery. In this webinar, experts discuss how they are integrating these tools across the full patient journey in real-world use cases. 🎥 Watch the webinar: ascoai.org/videos/webinar…
0
2
5
0
507
oncodaily's profile picture. Your daily dose of hope, inspiration, and information in the fight against cancer. OncoDaily - The Voice of Oncology
OncoDaily
@oncodaily
6 h

Translating Biology into Therapy in Colorectal Cancer - Nieves Martinez Lago (@DraMartinezLago) oncodaily.com/voices/nieves-… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

oncodaily's tweet image. Translating Biology into Therapy in Colorectal Cancer - Nieves Martinez Lago (@DraMartinezLago) oncodaily.com/voices/nieves-… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter
0
0
2
0
78
GENbio's profile picture. Serving the biotech industry since 1981. EIC @johnsterling4; publisher @liebertpub Subscribe to GEN: https://t.co/KzqMccOt9Q
Genetic Engineering & Biotechnology News
 @GENbio
Apr 13

GEN is heading to #AACR2026 in San Diego! Find our editors at Booth #3854, April 17-22. Stop by and connect. #Oncology #CancerResearch

GENbio's tweet image. GEN is heading to #AACR2026 in San Diego! Find our editors at Booth #3854, April 17-22. Stop by and connect. #Oncology #CancerResearch
0
1
3
1
458
oncodaily's profile picture. Your daily dose of hope, inspiration, and information in the fight against cancer. OncoDaily - The Voice of Oncology
OncoDaily
@oncodaily
12 h

Parker Institute for Cancer Immunotherapy (@parkerici) - Antoni Ribas Honored With the 2026 AACR-Margaret Foti Award oncodaily.com/voices/pici-48… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

oncodaily's tweet image. Parker Institute for Cancer Immunotherapy (@parkerici) - Antoni Ribas Honored With the 2026 AACR-Margaret Foti Award oncodaily.com/voices/pici-48… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter
0
1
4
0
141
ASCOPost's profile picture. News and views from the world of clinical oncology and hematology
The ASCO Post
 @ASCOPost
Apr 16

🔬 Integrating #AI into the #oncology workflow LLMs may capture key genomic and histologic findings in #pathology summaries more consistently than physician summaries. ➡️ Reduce errors, documentation burden 🔹 Mohamed E. Abazeed, MD, PhD | @JCOCCI_ASCO ascopost.com/news/april-202…

ASCOPost's tweet image. 🔬 Integrating #AI into the #oncology workflow LLMs may capture key genomic and histologic findings in #pathology summaries more consistently than physician summaries. ➡️ Reduce errors, documentation burden 🔹 Mohamed E. Abazeed, MD, PhD | @JCOCCI_ASCO ascopost.com/news/april-202…
1
3
2
0
562
NEJM's profile picture. The New England Journal of Medicine is the world’s leading medical journal and website.
NEJM
@NEJM
Apr 25

Original Article: Transdermal Estradiol Patches in Locally Advanced Prostate Cancer (STAMPEDE-1 and PATCH trials) nejm.org/doi/full/10.10… #Oncology

NEJM's tweet image. Original Article: Transdermal Estradiol Patches in Locally Advanced Prostate Cancer (STAMPEDE-1 and PATCH trials) nejm.org/doi/full/10.10… #Oncology
0
5
23
4
7K
oncodaily's profile picture. Your daily dose of hope, inspiration, and information in the fight against cancer. OncoDaily - The Voice of Oncology
OncoDaily
@oncodaily
7 h

ESMO - One Week Left to Apply for Leadership and Career Development Award @myESMO oncodaily.com/voices/esmo-49… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX

oncodaily's tweet image. ESMO - One Week Left to Apply for Leadership and Career Development Award @myESMO oncodaily.com/voices/esmo-49… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX
0
1
3
0
60
ASCOPost's profile picture. News and views from the world of clinical oncology and hematology
The ASCO Post
 @ASCOPost
Apr 7

🖥️ #ASCOAI: @drsarahsam of @dfci_breastonc reflects on how #AI is and will continue to transform #oncology practice, potentially impacting the practice of second opinions. Read her perspective here: ascoai.org/articles/2026/…

ASCOPost's tweet image. 🖥️ #ASCOAI: @drsarahsam of @dfci_breastonc reflects on how #AI is and will continue to transform #oncology practice, potentially impacting the practice of second opinions. Read her perspective here: ascoai.org/articles/2026/…
2
5
5
3
773
Entisar_kilani's profile picture. Board-Certified Internist | Fellow in Medical Oncology & Hematology. | Passionate about patient care & staying up-to-date on advancements in the field. .
Entisar saleh
 @Entisar_kilani
Apr 16

Top 10 breast cancer updates by oncodaily breast . oncodaily.com/oncolibrary/br… #breast #oncology #oncodaily

Entisar_kilani's tweet image. Top 10 breast cancer updates by oncodaily breast . oncodaily.com/oncolibrary/br… #breast #oncology #oncodaily
0
19
44
22
2K
OncLive's profile picture. Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
OncLive.com
@OncLive
Apr 12

Ana Oaknin, MD, PhD, just gave an excellent presentation on the BEHOLD-1 study of mocertatug rezetecan in ovarian and endometrial cancers! Stay tuned to onclive.com for our full breakdown of the data. #SGOAM26 #gynsm #oncology @SGO_org

OncLive's tweet image. Ana Oaknin, MD, PhD, just gave an excellent presentation on the BEHOLD-1 study of mocertatug rezetecan in ovarian and endometrial cancers! Stay tuned to onclive.com for our full breakdown of the data. #SGOAM26 #gynsm #oncology @SGO_org
OncLive's tweet image. Ana Oaknin, MD, PhD, just gave an excellent presentation on the BEHOLD-1 study of mocertatug rezetecan in ovarian and endometrial cancers! Stay tuned to onclive.com for our full breakdown of the data. #SGOAM26 #gynsm #oncology @SGO_org
OncLive's tweet image. Ana Oaknin, MD, PhD, just gave an excellent presentation on the BEHOLD-1 study of mocertatug rezetecan in ovarian and endometrial cancers! Stay tuned to onclive.com for our full breakdown of the data. #SGOAM26 #gynsm #oncology @SGO_org
OncLive's tweet image. Ana Oaknin, MD, PhD, just gave an excellent presentation on the BEHOLD-1 study of mocertatug rezetecan in ovarian and endometrial cancers! Stay tuned to onclive.com for our full breakdown of the data. #SGOAM26 #gynsm #oncology @SGO_org
0
4
8
3
893

Something went wrong.


Something went wrong.


United States Trends